uniQure NV (QURE)

[chmcnfunds]

Uniqure NV’s (QURE) “Buy” Rating Reaffirmed at Chardan Capital

Posted by mitch on Mar 24th, 2016 // No Comments

Uniqure NV logoChardan Capital reiterated their buy rating on shares of Uniqure NV (NASDAQ:QURE) in a research report released on Wednesday, Analyst Ratings Network.com reports. Chardan Capital currently has a $40.00 price objective on the stock.

Several other analysts have also commented on the stock. Zacks Investment Research lowered shares of Uniqure NV from a buy rating to a hold rating in a research report on Wednesday, November 25th. Cowen and Company reissued a buy rating on shares of Uniqure NV in a research report on Monday, November 30th. Leerink Swann reissued an outperform rating and set a $48.00 price target on shares of Uniqure NV in a research report on Friday, January 8th. Janney Montgomery Scott started coverage on shares of Uniqure NV in a research report on Monday, November 30th. They set a buy rating and a $40.00 price target for the company. Finally, Piper Jaffray reissued an overweight rating and set a $35.00 price target on shares of Uniqure NV in a research report on Wednesday, January 6th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. The stock currently has an average rating of Buy and a consensus price target of $40.36.

A number of institutional investors have modified their holdings of the company. Tocqueville Asset Management L.P. increased its position in shares of Uniqure NV by 5.6% in the fourth quarter. Tocqueville Asset Management L.P. now owns 79,750 shares of the company’s stock valued at $1,319,000 after buying an additional 4,200 shares during the period. Deutsche Bank AG increased its position in shares of Uniqure NV by 53.2% in the fourth quarter. Deutsche Bank AG now owns 112,088 shares of the company’s stock valued at $1,853,000 after buying an additional 38,943 shares during the period. Columbus Circle Investors increased its position in shares of Uniqure NV by 493.7% in the fourth quarter. Columbus Circle Investors now owns 113,548 shares of the company’s stock valued at $1,878,000 after buying an additional 94,422 shares during the period. Eventide Asset Management LLC increased its position in shares of Uniqure NV by 12.9% in the fourth quarter. Eventide Asset Management LLC now owns 174,900 shares of the company’s stock valued at $2,893,000 after buying an additional 20,000 shares during the period. Finally, Perceptive Advisors LLC increased its position in shares of Uniqure NV by 40.1% in the fourth quarter. Perceptive Advisors LLC now owns 967,093 shares of the company’s stock valued at $15,996,000 after buying an additional 276,824 shares during the period.

Shares of Uniqure NV (NASDAQ:QURE) opened at 11.86 on Wednesday. The company’s market capitalization is $287.23 million. Uniqure NV has a 1-year low of $10.61 and a 1-year high of $36.38. The firm’s 50-day moving average is $14.06 and its 200-day moving average is $18.11.

Uniqure NV is a pharmaceutical company based in the Netherlands. It is primarily engaged in the field of gene therapy for orphan diseases. The Company is focused on patients suffering from genetic or acquired diseases by directing the expression of a therapeutic protein or restoring the expression of a missing protein through a single administration.
____________________________________________
http://www.thevistavoice.org/2016/03/24/uniqure-nvs-qure-buy-rating-reaffirmed-at-chardan-capital/983946/

QURE